Partnership Diabetes

Persoon controleert bloedwaarde

About this programme

Partnership Diabetes

Over 1 million Dutch people live with the consequences of type 2 diabetes. Worldwide this number has increased to 400 million. Much has been learned about the pathogenesis of diabetes and new important treatments have been generated over the past century; however, the prevalence of type 2 diabetes is increasing dramatically as are the associated complications. By partnering with (international) partners ZonMw wants to accelerate research to prevent or reverse type 2 diabetes. This programme consists of two rounds, the Diabetes II Breakthrough projects and the international collaboration Netherlands-Canada Diabetes Research Consortium.

Diabetes II breakthrough projects

Diabetes II Breakthrough Projects is a joint initiative of ZonMw and the Dutch Diabetes Research Foundation to provide grants for research into type 2 diabetes. The goal is to encourage researchers to devise and test innovative, high-risk and groundbreaking solutions with potentially high clinical impacts that will contribute to the battle against type 2 diabetes. Diabetes II Breakthrough Projects provides researchers the opportunity to test and prove their solutions in a pilot study of maximum 12 months. A single question will prevail throughout: which new knowledge is going to make the most important difference in the battle to prevent and cure type 2 diabetes?

International Diabetes Research Consortium

ZonMw, The Canadian Institutes of Health Research (CIHR), the Dutch Diabetes Research Foundation and Health~Holland have joined forces and created the joint program Netherlands-Canada Type 2 Diabetes Research Consortium. Through one international consortium we aim to support research with a considerable economic and societal impact that focuses on reversal or remission of type 2 diabetes or pre-diabetes, that improves the quality of life for individuals with type 2 diabetes and their families and that leads to sustainable collaborations between Dutch and Canadian type 2 diabetes researchers.


In progress
€ 2.000.000
Duration: 71%
Duration: 71 %


Nathalie Swier

swier [at]